-
GameStop COO, Dogelon Mars Surge, Snowden On Shiba Inu, J&J Settlement, Cathie Wood's FB Bet: 5 Headlines You May Have Missed From This Weekend
Monday, November 1, 2021 - 6:30am | 638Read More...Heading into a new trading week, here is a quick roundup of the top five stories from the technology, corporate and cryptocurrency sectors that investors would not want to miss out on from the weekend. 1. Johnson & Johnson Settles Risperdal Lawsuits: Johnson & Johnson (NYSE: JNJ) said...
-
J&J Settles Anti-psychotic Drug Risperdal Lawsuits With $800 Million In Expenses
Saturday, October 30, 2021 - 2:24pm | 371Read More...Johnson & Johnson (NYSE: JNJ) says it has settled most of the lawsuits in the anti-psychotic drug Risperdal cases and has recorded $800 million in expenses in connection with the agreement. The medical devices and pharmaceuticals maker had almost 9000 cases over the Risperdal drug,...
-
Analysts, Investors Like Johnson & Johnson's Improvement, But Lawsuits Loom
Wednesday, October 16, 2019 - 2:26pm | 680Read More...Johnson & Johnson (NYSE: JNJ) stock was on the rise Wednesday following better-than-expected third-quarter earnings and guidance, but analysts are mostly leery of boosting recommendations in light of a string of legal challenges the company faces. The Analysts Morgan Stanley’s...
-
Johnson & Johnson Hit With $8B Verdict In Risperdal Lawsuit
Wednesday, October 9, 2019 - 9:05am | 452Read More...Johnson & Johnson (NYSE: JNJ) is reaching deeper in its pockets to comply with the verdict of its second major lawsuit this month. What Happened On Wednesday, a Philadelphia court ordered Johnson & Johnson to pay $8 billion in damages to a Risperdal consumer who said the company had failed...
-
Johnson & Johnson Reaches Risperdal Lawsuit Agreement
Friday, August 3, 2012 - 12:56pm | 293Read More...Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) and the Department of Justice have reached an agreement in principle to the illegal marketing practices of antipsychotic drug Risperdal. In the drug maker's securities filing it indicated “issues remain open” before settlements can be...
